Acute Myeloblastic Leukemia

Explore clinical trials studying Acute Myeloblastic Leukemia. Study availability and eligibility vary by location and protocol.

17 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Acute Myeloblastic Leukemia trial results

Completed

Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia

NCT01435343

Conditions: Acute Myeloblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Hospital Universitari Germans Trials i Pujol Badalona, Spain

Hospital Clínic de Barcelona Barcelona, Spain

Hospital de la Santa Creu i Sant Pau. Barcelona, Spain

Hospital Duran i Reynals - ICO L'Hospitalet Barcelona, Spain

View Trial Details

Completed

Natural Killer Index From Hematopoietic Stem Cell Graft

NCT00435864

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloblastic Leukemia, Bone Marrow Diseases, +20 more
Locations: CHU de Nantes Nantes, France

View Trial Details

Completed

LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML)

NCT01041040

Conditions: Acute Myeloblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Hoapital La Fe Valencia, Spain

View Trial Details

Completed

Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients

NCT00504920

Conditions: Acute Myeloblastic Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Treatment of Acute Myeloblastic Leukemia in Younger Patients

NCT00390715

Conditions: Acute Myeloblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Hospital General de Alicante Alicante, Spain

Hospital Clínic Barcelona, Spain

Hospital de la Santa Creu i Sant Pau Barcelona, Spain

Hospital del Mar Barcelona, Spain

View all 42 locations

View Trial Details

Completed

SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia

NCT00487448

Conditions: Acute Myeloblastic Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Hospital de la Ribera Alzira, Spain

Hospital Germans Trias i Pujol Badalona, Spain

Hospital del Mar Barcelona, Spain

Hospital Vall d'Hebron Barcelona, Spain

View all 15 locations

View Trial Details

Completed

Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children

NCT00552825

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloblastic Leukemia, Hematologic Diseases, +17 more
Locations: Sheba Medical CenterPediatric pulmonary unit, Pulmonary function laboratory Ramat Gan, Israel

View Trial Details

Acute Myeloblastic Leukemia

Acute Myeloblastic Leukemia trial results

Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia

Natural Killer Index From Hematopoietic Stem Cell Graft

LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML)

Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients

Treatment of Acute Myeloblastic Leukemia in Younger Patients

SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia

Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children

Related conditions